Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INT (Integrated Nano-Technologies) presses on with portable electronic DNA technology:

This article was originally published in Clinica

Executive Summary

Integrated Nano-Technologies (INT) predicts that its portable biological agent detection system could be ready for commercialisation in early 2004. The BioDetect system is a low cost, electronic-based, DNA detection system that can test for agents, such as anthrax, smallpox and SARS in minutes, says the Rochester, New York firm. Weighing around 12lbs, the simple-to-operate device can be used independently or integrated into existing systems, and requires minimal sample preparation. It consists of an electronic analyser and single-use, disposable test cards. It can test for hundreds of targets from a single sample. The system is expected to undergo testing shortly.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel